Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

NCT00136045 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

549

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Rotigotine

Sponsor

UCB Pharma